Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Classifica tra le azioni #41
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Prezzo delle azioni
$459.10
Ultima sincronizzazione: 2026-09-11
Capitalizzazione di mercato
$359.91B
Variazione (1 giorno)
0.11%
Variazione (1 anno)
30.72%
Paese
CH
Scambia Roche Holding AG (RO)

Categoria

Utile per Roche Holding AG (RO)
Utile nel Dec 2025 TTM: $21.39B
Secondo gli ultimi rapporti finanziari di Roche Holding AG, gli utili attuali della società sono $21.39B. Nel 2024, la società ha registrato un utile di $13.06B, una diminuzione rispetto a agli utili del 2023, che erano di $16.74B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Roche Holding AG dal 2000 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $21.39B 0.00%
2025 $21.39B 63.83%
2024 $13.06B -22.02%
2023 $16.74B -5.44%
2022 $17.70B -7.24%
2021 $19.09B -4.57%
2020 $20.00B 16.46%
2019 $17.17B 19.41%
2018 $14.38B 14.44%
2017 $12.57B -1.66%
2016 $12.78B 6.57%
2015 $11.99B -4.81%
2014 $12.60B -23.40%
2013 $16.45B 22.16%
2012 $13.46B 6.42%
2011 $12.65B 5.47%
2010 $12.00B 21.15%
2009 $9.90B -25.31%
2008 $13.26B -2.09%
2007 $13.54B 31.16%
2006 $10.32B 51.54%
2005 $6.81B -18.34%
2004 $8.34B 111.44%
2003 $3.95B -270.88%
2002 $-2.31B -180.67%
2001 $2.86B -50.86%
2000 $5.82B 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$33.59B 57.07%
US
$25.20B 17.80%
US
$8.70B -59.33%
US
$5.95B -72.19%
US
$16.38B -23.42%
CH